Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38047
CAS Number:
89226-75-5
Dihidrocloruro de manidipino
Purity:
98 - 101% (ensayo)
Synonym(s):
Clorhidrato de éster metílico de 2-[4-(difenilmetil)-1-piperazinil]etilo y ácido 1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridinadicarboxílico, Clorhidrato de metil1,4-dihidro-2,6-dimetil-4-(3-nitrofenil)-3,5-piridinadicarboxilato de 2-[4-(difenilmetil)-1-piperazinil]etilo
Hazmat
Documents
$181.67 /1G
Tamaño
Request Bulk Quote
Información del producto
Número CAS
89226-75-5
Fórmula molecular
C35H38N4O6 · 2HCl
Peso molecular
0
Número MDL
MFCD00896434
Punto de fusión
~207 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
89226-75-5
Fórmula molecular
C35H38N4O6 · 2HCl
Peso molecular
0
Número MDL
MFCD00896434
Punto de fusión
~207 °C (descenso)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Manidipine dihydrochloride is widely utilized in research focused on:

  • Hypertension Treatment: This compound is primarily used in the pharmaceutical industry for managing high blood pressure, providing effective vasodilation and reducing cardiovascular risks.
  • Cardiovascular Research: Researchers often explore its effects on heart health, studying its mechanisms to improve blood flow and reduce strain on the heart.
  • Combination Therapies: It is frequently combined with other antihypertensive agents to enhance therapeutic efficacy, allowing for lower doses and reduced side effects.
  • Drug Development: In the field of medicinal chemistry, it serves as a model compound for developing new antihypertensive medications, guiding the design of more effective and safer drugs.
  • Clinical Trials: Manidipine dihydrochloride is often involved in clinical studies to assess its long-term effects and benefits, contributing valuable data to the medical community.

Citas